Renal Sodium Transport in the Obese Zucker Rat
肥胖 Zucker 大鼠的肾钠转运
基本信息
- 批准号:7340799
- 负责人:
- 金额:$ 2.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-01 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgeAgonistAldosteroneAngiotensin IIAngiotensin-Converting Enzyme InhibitorsAngiotensinsAutoradiographyBindingBlood PressureCanrenoneCarrier ProteinsCollagen Type IVDataDiabetes MellitusDietDisease modelDistalDown-RegulationEnalaprilEndocrineEnzymesEpithelialEquilibriumEtiologyFibronectinsGlucocorticoidsGoalsHomeostasisHormonesHyperinsulinismHypertensionHypertrophyIn SituIn Situ HybridizationIn VitroInfusion proceduresInsulinInsulin ReceptorInsulin ResistanceKidneyKidney DiseasesLaboratoriesLocationMessenger RNAMineralocorticoid ReceptorMineralocorticoidsModelingMolecularNa(+)-K(+)-Exchanging ATPaseNatriuresisObesityPPAR gammaPartner in relationshipPathologyPatternPhosphorylationPlasmaPlayProcessProtein Tyrosine KinaseProteinsRangeRattusReceptor SignalingRegulationRelative (related person)Renal HypertensionRenal tubule structureReninRenin-Angiotensin-Aldosterone SystemResearch PersonnelRoleSeriesSignal TransductionSignaling ProteinSodiumSodium ChannelSodium ChlorideSteroidsSystemTestingUp-RegulationVasopressinsWaterWeekZucker Ratsage relatedagedblood pressure regulationcandesartandaydesigndietary restrictionepithelial Na+ channelmRNA Expressionpreventprogramsprotein expressionreceptorreceptor bindingreceptor expressionresponserosiglitazonesalureticthiazidewater channel
项目摘要
Obesity and insulin resistance are associated with hypertension. Inappropriate retention of sodium by the
kidney is likely to play a major role. We previously showed that the obese Zucker rat (a model for these
disorders) have increased renal protein abundance for three major sodium transport proteins: the alpha-1
subunit of Na-K-ATPase, the thiazide-sensitive NaCI cotransporter (NCC or TSC) and the beta-subunit of the
epithelial sodium channel (ENaC). In contrast, as, they aged, obese rats developed renal hypertrophy along
with diabetes and had a relative decrease in many important salt and water transport proteins, as compared
to age-matched controls. We suggest that dysregulation of several important hormone systems in sodium
balance may play a role in both alterations in sodium transport protein expression, as well as, the rapid
develop of nephropathy. Candidate systems include the renin-angiotensin-aldosterone system (RAAS) and
insulin (and or insulin resistance). We hypothesize that dysregulation of major sodium transport proteins of
the kidney in the obese Zucker rat with age, is due at least in part to increased RAAS activity, and
hyperinsulinemia, which in combination, result in inappropriate sodium retention and elevated blood
pressure. Our specific aims include: 1) to determine if angiotensin II ATla receptor expression, binding, and
activity is upregulated in the obese Zucker rat and whether this upregulation plays a role in changes in renal
sodium transporter regulation, blood pressure, and renal hypertrophy; 2) to determine if enhanced
mineratocorticoid receptor (MR) activity plays a role in increased whole kidney protein abundance of the
thiazide-sensitive NaCI cotransporter (NCC), blood pressure, and renal hypertrophy, in the obese Zucker rat;
3) to determine the cellular location and sensitivity of the renal insulin receptor in obese Zucker rats relative
to lean age-mates; 4) to determine whether treatment of insulin resistance with a PPAR-gamma agonist will
decrease relative renal protein abundance of NCC, beta-ENaC, and Na-K-ATPase, as well as reduce blood
pressure and renal hypertrophy in the obese Zucker rat, and whether these effects are reversed with short-
term insulin infusion. These studies will allow us to determine the importance of each of these potential
regulatory hormone systems in dyregulation of sodium transporter expression, sodium balance, and blood
pressure in these obese rats.
肥胖和胰岛素抵抗与高血压有关。钠的不适当保留
肾脏可能发挥重要作用。我们之前表明,肥胖的 Zucker 大鼠(这些大鼠的模型)
疾病)增加了三种主要钠转运蛋白的肾蛋白丰度:α-1
Na-K-ATP 酶亚基、噻嗪类敏感的 NaCl 协同转运蛋白(NCC 或 TSC)和 β 亚基
上皮钠通道(ENaC)。相比之下,随着年龄的增长,肥胖大鼠的肾脏随之出现肥大。
与糖尿病患者相比,许多重要的盐和水转运蛋白相对减少
到年龄匹配的控制。我们认为钠中几种重要激素系统的失调
平衡可能在钠转运蛋白表达的改变以及快速钠转运蛋白表达的改变中发挥作用。
发展为肾病。候选系统包括肾素-血管紧张素-醛固酮系统(RAAS)和
胰岛素(和/或胰岛素抵抗)。我们假设主要钠转运蛋白的失调
肥胖 Zucker 大鼠的肾脏随着年龄的增长,至少部分是由于 RAAS 活性增加,并且
高胰岛素血症,两者结合起来会导致不适当的钠潴留和血液升高
压力。我们的具体目标包括:1) 确定血管紧张素 II ATla 受体的表达、结合和
肥胖 Zucker 大鼠的活性上调,以及这种上调是否在肾功能变化中发挥作用
钠转运蛋白调节、血压和肾肥大; 2)判断是否增强
盐皮质激素受体 (MR) 活性在增加全肾蛋白丰度中发挥作用
肥胖 Zucker 大鼠中噻嗪类敏感的 NaCl 协同转运蛋白 (NCC)、血压和肾肥大;
3)确定肥胖Zucker相关大鼠肾胰岛素受体的细胞位置和敏感性
依靠同龄人; 4) 确定用 PPAR-γ 激动剂治疗胰岛素抵抗是否会有效
降低 NCC、β-ENaC 和 Na-K-ATP 酶的相对肾蛋白丰度,并减少血液
肥胖 Zucker 大鼠的压力和肾肥大,以及这些影响是否可以通过短时间逆转
定期胰岛素输注。这些研究将使我们能够确定这些潜力的重要性
调节激素系统对钠转运蛋白表达、钠平衡和血液的失调
这些肥胖老鼠的压力。
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rosiglitazone regulates ENaC and Na-K-2Cl cotransporter (NKCC2) abundance in the obese Zucker rat.
Rosiglitazone 调节肥胖 Zucker 大鼠中的 ENaC 和 Na-K-2Cl 协同转运蛋白 (NKCC2) 丰度。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:4.2
- 作者:Riazi, Shahla;Khan, Osman;Tiwari, Swasti;Hu, Xinqun;Ecelbarger, Carolyn A
- 通讯作者:Ecelbarger, Carolyn A
Sex differences in adaptive downregulation of pre-macula densa sodium transporters with ANG II infusion in mice.
小鼠 ANG II 输注对致密斑前钠转运蛋白适应性下调的性别差异。
- DOI:
- 发表时间:2010-01
- 期刊:
- 影响因子:0
- 作者:Tiwari, Swasti;Li, Lijun;Riazi, Shahla;Halagappa, Veerendra K Madala;Ecelbarger, Carolyn M
- 通讯作者:Ecelbarger, Carolyn M
Increased renal alpha-ENaC and NCC abundance and elevated blood pressure are independent of hyperaldosteronism in vasopressin escape.
肾脏 α-ENaC 和 NCC 丰度增加以及血压升高与加压素逃逸中醛固酮增多症无关。
- DOI:
- 发表时间:2006-07
- 期刊:
- 影响因子:0
- 作者:Tiwari, Swasti;Packer, Randall K;Hu, Xinqun;Sugimura, Yoshihisa;Verbalis, Joseph G;Ecelbarger, Carolyn A
- 通讯作者:Ecelbarger, Carolyn A
17-beta Estradiol attenuates streptozotocin-induced diabetes and regulates the expression of renal sodium transporters.
17-β 雌二醇可减轻链脲佐菌素诱导的糖尿病并调节肾钠转运蛋白的表达。
- DOI:
- 发表时间:2006-02
- 期刊:
- 影响因子:19.6
- 作者:Riazi, S;Maric, C;Ecelbarger, C A
- 通讯作者:Ecelbarger, C A
Regulation of the renal thiazide-sensitive Na-Cl cotransporter, blood pressure, and natriuresis in obese Zucker rats treated with rosiglitazone.
用罗格列酮治疗的肥胖 Zucker 大鼠对肾脏噻嗪类敏感的 Na-Cl 协同转运蛋白、血压和尿钠的调节。
- DOI:
- 发表时间:2005-08
- 期刊:
- 影响因子:0
- 作者:Khan, Osman;Riazi, Shahla;Hu, Xinqun;Song, Jian;Wade, James B;Ecelbarger, Carolyn A
- 通讯作者:Ecelbarger, Carolyn A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carolyn Mary Ecelbarger其他文献
Carolyn Mary Ecelbarger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carolyn Mary Ecelbarger', 18)}}的其他基金
Renal Sodium Transport in the Obese Zucker Rat
肥胖 Zucker 大鼠的肾钠转运
- 批准号:
6747709 - 财政年份:2003
- 资助金额:
$ 2.33万 - 项目类别:
Renal Sodium Transport in the Obese Zucker Rat
肥胖 Zucker 大鼠的肾钠转运
- 批准号:
7073450 - 财政年份:2003
- 资助金额:
$ 2.33万 - 项目类别:
NaCI Balance and Targeted Insulin Receptor Knockout Mice
NaCI 平衡和靶向胰岛素受体基因敲除小鼠
- 批准号:
6762353 - 财政年份:2003
- 资助金额:
$ 2.33万 - 项目类别:
Insulin, Renal Sodium Transport and Blood Pressure
胰岛素、肾钠转运和血压
- 批准号:
6929844 - 财政年份:2003
- 资助金额:
$ 2.33万 - 项目类别:
Insulin, Renal Sodium Transport and Blood Pressure
胰岛素、肾钠转运和血压
- 批准号:
7103515 - 财政年份:2003
- 资助金额:
$ 2.33万 - 项目类别:
相似国自然基金
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GNAS介导OPN4-PLCβ4-TRPC6/7通路调节自主感光视网膜神经节细胞在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301229
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
The Impact of Surgery on Outcomes for Patients taking Medications for Opioid Use Disorder
手术对服用阿片类药物使用障碍患者的结果的影响
- 批准号:
10793072 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
The Tissue-Specific Functionality of the Farnesoid X Receptor in NASH Development
Farnesoid X 受体在 NASH 发展中的组织特异性功能
- 批准号:
10750016 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Protease-activated-receptor-2 antagonists for treatment of migraine pain
蛋白酶激活受体 2 拮抗剂治疗偏头痛
- 批准号:
10602826 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Toward Repurposing a Commonly-Used Medication for the Treatment of Pediatric Severe Obesity
重新利用治疗儿童严重肥胖症的常用药物
- 批准号:
10711874 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Novel behavioral screening tool for therapeutics against organophosphorus agents
用于有机磷药物治疗的新型行为筛选工具
- 批准号:
10631009 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别: